GALECTIN 3 AND ALDOSTERONE IN PATIENTS WITH ATRIAL FIBRILLATION AND METABOLIC SYNDROME

Aim. To study the levels of galectin 3 and aldostrone in blood serum of metabolic syndrome (MS) patients and atrial fibrillation (AF) for their importance evaluation. Material and methods. Totally 100 patients with MS (IDF, 2005) studied, of those 50 with AF: 28 with paroxysmal and 22 with persisten...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Rossiĭskiĭ kardiologicheskiĭ zhurnal 2015-11 (4), p.79-83
Hauptverfasser: Lonin, V. A., Soboleva, A. V., Listopad, O. V., Nifontov, S. E., Bazhenova, E. A., Vasilieva, E. Yu, Baranova, E. I., Shlyakhto, E. V.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aim. To study the levels of galectin 3 and aldostrone in blood serum of metabolic syndrome (MS) patients and atrial fibrillation (AF) for their importance evaluation. Material and methods. Totally 100 patients with MS (IDF, 2005) studied, of those 50 with AF: 28 with paroxysmal and 22 with persistent types. Controls were 50 almost healthy persons without cardiovascular pathology and metabolic disorders. Levels of galectin 3 and aldosterone in serum were measured by ELISA. All participants also underwent anthropometry, lipid profile and fasting glycemia measurements, transthoracal echocardiography.Results. Galectin 3 level in MS and AF patients' serum was higher than in MS without AF and than in healthy persons (0,72 [0,44;1,36], 0,44 [0,42;1,22] and 0,32[0,28;0,42]ng/ml, resp.; p
ISSN:1560-4071
2618-7620
DOI:10.15829/1560-4071-2015-4-79-83